TSHA

TSHA CapEx to Revenue

61.64%TTM

Retrieved:

TSHA FY CapEx/Revenue%
TSHA FY CapEx/Revenue1113.24%-119.28%
2019-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

TSHA capex to revenue history

Capital expenditure as percentage of revenue. The available annual fiscal periods series contains 7 observations from Dec 31, 2019 to Dec 31, 2025.

Taysha Gene Therapies Inc CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
7.5514%
4.4882%
47.6927%
993.9648%
0%
0%
0%

Compare capex to revenue

All TSHA financial metrics · TSHA stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.